Staging in oesophageal cancer

Area of Science:

• Oncology
• Medical Imaging
• Gastroenterology

Background:

• Accurate staging is crucial for stage-specific treatment of esophageal cancer, minimizing overtreatment.
• Advanced imaging techniques like multidetector computed tomography (CT), endoscopic ultrasonography with fine-needle aspiration (EUS-FNA), and positron emission tomography (PET) enhance staging accuracy.

Purpose of the Study:

• To evaluate the role of advanced imaging in esophageal cancer staging.
• To compare the effectiveness of different staging modalities, including PET/CT and EUS-FNA.
• To explore the utility of FDG PET in assessing neoadjuvant treatment response.

Main Methods:

• Review of dedicated staging methods for esophageal cancer.
• Analysis of positron emission tomography (PET) combined with computed tomography (PET/CT) for non-invasive staging.
• Consideration of endoscopic ultrasonography with fine-needle aspiration (EUS-FNA).

Main Results:

• PET/CT improves non-invasive staging accuracy, especially for locally advanced esophageal cancer.
• The optimal sequence of EUS-FNA versus PET/CT remains under investigation.
• Fluorodeoxyglucose (FDG) PET shows promise in evaluating neoadjuvant treatment response.

Conclusions:

• Dedicated staging methods like PET/CT and EUS-FNA are vital for accurate esophageal cancer staging.
• Centralization may be beneficial due to the learning curve associated with these advanced techniques.